Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 22, 2024 9:08am
New Press Release - PharmAla Launches MDMA Clinical Trial Tool for Researchers
TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to...
read article.
(22)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Aug 21, 2024 8:28am
A for effort
Over and over and over , every stock I've seen you on chef !!!!!
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 20, 2024 3:34pm
shorting a stock down
and then manipulating it back up IS NOT how you create FOMO!
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 20, 2024 2:57pm
you think the ceo.ca traders are SHORT???
LOL.....like i said these people are criminals
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 20, 2024 1:49pm
at 0.06 this stock was trash to the ceo traders?
but at 0.085 and 0.09 lots of support? see the kind of joke these people are
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 18, 2024 8:41am
public markets are trash
new entrants do not understand, but i do. Been here long enough to know there are a lot of things going on in the background that investors DO NOT SEE! A LOT. In this case, we have a stock and
...more
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Comment by
Chefboy69
on Aug 16, 2024 1:19pm
RE:The fall from grace...they spit in your face.
well ceo is rockin??
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 16, 2024 1:19pm
Lots willing to grab shares
it can;t be that bad of a company
(3)
•••
Firepoker1
X
View Profile
View Bullboard History
Post by
Firepoker1
on Aug 16, 2024 12:46pm
The fall from grace...they spit in your face.
So sad to see the steady decline in MDMA, but is even worse is the glee of greed..
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Aug 13, 2024 1:01pm
RE:lots of interest when this stock goes DOWN??
Comparing Pharmala to other juniors in the industry it definitely looks to be the most attractive. $7.34 million market cap, only 91.27 million shares outstanding, -0.01 EPS, a CEO that
...more
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 13, 2024 11:10am
potential defamation
when its the truth? thats funny
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 13, 2024 10:21am
burner accounts on ceo allowed
for a select few
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Aug 13, 2024 10:19am
lots of interest when this stock goes DOWN??
but bot too much when it has a chance to go up? and forces wanting to keep it down??? because they were denied a PP???? so crazy
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Aug 12, 2024 10:47pm
RE:Re: FDA Decision
Thanks! However, I don't feel the stock should have taken any hit today with the patent announcement. The FDA's panel vote had already done more damage than this company deserved
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >